A Rare Case of Dural Tail Sign in the Patient with Glioblastoma Multiforme: A Case Report
Downloads
Highlight:
- A dural tail sign was found in T1W1-MR-images with contrast of a patient with glioblastoma multiforme.
- Glioblastoma multiforme as a grade IV malignancy of the astrocytes' glioma, the dura mater can be infiltrated and shown as DTS, although rarely reported.
ABSTRACT
Introduction: The dural tail sign (DTS), which is rarely seen in patients with glioblastoma multiforme (GBM), is reported here. This sign is generally found as a manifestation of meningioma due to the reactive changes of the tumor's invasion. Case: A 61-year-old Javanese man presented with a gradually worsening headache two months prior to hospital admission. He also suffered from paralysis of his right extremities. His complete blood tests and clinical chemistry were within normal limits. A head CT scan showed a large mass near the convexity of the brain in the left parietal lobe, along with edema and a shift of the midline structures to the right. This was confirmed on the T1W1 MR images with contrast, where DTS was clearly shown. Following surgical resection and tumor excision, histopathology analysis revealed GBM with malignant cell infiltration to the dura in the vicinity of the neoplasm. Conclusion: Here we showed a DTS in GBM as a malignant infiltration marker into the dura
Sotoudeh H. A review on dural tail sign. World J Radiol. 2010;2(5):188.
Wilms G, Lammens M, Marchal G, Calenbergh F Van, Plets C, Fraeyenhoven L Van, et al. Thickening of dura surrounding meningiomas: MR Features. J Comput Assist Tomogr. 1989;13(5).
Guermazi A, Lafitte F, Miaux Y, Adem C, Bonneville J-F, Chiras J. The dural tail sign”beyond meningioma. Clin Radiol. 2005;60(2):171–88.
Doddamani RS, Meena RK, Sawarkar D. Ambiguity in the dural tail sign on MRI. Surg Neurol Int. 2018;9(1).
Hadidchi S, Surento W, Lerner A, Liu C-SJ, Gibbs WN, Kim PE, et al. Headache and brain tumor. Neuroimaging Clin N Am. 2019;29(2):291–300.
Alentorn A, Hoang-Xuan K, Mikkelsen T. Chapter 2 - Presenting signs and symptoms in brain tumors. In: Berger MS, Weller MBT-H of CN, editors. Gliomas. Elsevier; 2016. p. 19–26.
Brandí£o LA, Castillo M. Adult brain tumors: Clinical applications of magnetic resonance spectroscopy. Magn Reson Imaging Clin N Am. 2016;24(4):781–809.
Alifieris C, Trafalis DT. Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol Ther. 2015;152:63–82.
Patel M, Nguyen HS, Doan N, Gelsomino M, Shabani S, Mueller W. Glioblastoma mimicking meningioma: Report of 2 cases. World Neurosurg. 2016;95:624.e9.
Tamrazi B. Advanced Imaging of Cranial Meningiomas. Physiol Behav. 2016;27(1):137–43.
Li C, Xi S, Chen Y, Guo C, Zhang J, Yang Q, et al. Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center. BMC Cancer. 2023;23(1):1–9.
Mujagić S, Bećirević-IbriÅ¡ević J, Vržuljević-Martić V, Ercegović Z, Korkut D, Moranjkić M. Dural tail sign adjacent to different intracranial lesions on contrast-enhanced MR images. J Heal Sci. 2011;1(2):96–102.
Rayi A, Kobalka PJ. Histopathology of adult and pediatric glioblastoma. In: Otero JJ, Becker AP, editors. Precision Molecular Pathology of Glioblastoma. Cham: Springer International Publishing; 2021. p. 67–89.
Picot J, Cooper K, Bryant J, Clegg AJ. The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: A systematic review and economic evaluation. Health Technol Assess. 2011;15(41):1-104.
Pochettino F, Visconti G, Godoy D, Rivarola P, Crivelli A, Puga M, et al. Association between Karnofsky performance status and outcomes in cancer patients on home parenteral nutrition. Clin Nutr ESPEN. 2023;54:211–4.
Zhou K, Zhao Z, Li S, Liu Y, Li G, Jiang T. A new glioma grading model based on histopathology and bone morphogenetic protein 2 mRNA expression. Sci Rep. 2020;10(1):1–14.
Whitfield BT, Huse JT. Classification of adult"type diffuse gliomas: Impact of the World Health Organization 2021 update. Brain Pathol. 2022;32(4):e13062.
Mikkelsen VE, Solheim O, Salvesen í˜, Torp SH. The histological representativeness of glioblastoma tissue samples. Acta Neurochir (Wien). 2021;163(7):1911–20.
D'Alessio A, Proietti G, Sica G, Scicchitano BM. Pathological and molecular features of glioblastoma and its peritumoral tissue. Cancers (Basel). 2019;11(4).
Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific J Cancer Prev. 2017;18(1):3–9.
Copyright (c) 2023 Risdiansyah Risdiansyah, Kusuma Eko Purwantari, Viskasari P Kalanjati, Rahadian I Susilo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
